Una Health have a comprehensive range of COVID-19 tests available to suit all needs.
Please note that if you are purchasing a COVID-19 test kit outside of an accredited NHS laboratory you will be required to read and sign our disclaimer prior to purchase. All of our COVID-19 products MUST be administered by a healthcare professional and are not for home use.
Rapid antibody testing for SARS-CoV-2 (COVID-19). As used in the ongoing government funded, Imperial College led REACT surveillance study.
The Fortress COVID-19 Total Antibody Device is a single use, lateral flow device for the qualitative detection of total antibodies against 2019 novel coronavirus (SARS-CoV-2) in human serum, plasma or whole blood specimens.
Rapid antigen testing for SARS-CoV-2 (COVID-19). Rapid results when a timely diagnosis matters most for your #patientjourney
The Fortress Diagnostics Coronavirus Ag Rapid Test has successfully passed the Porton Down validation process.
The Fortress COVID-19 Antigen Test uses a simple test procedure using a nasal swab from individuals suspected of COVID-19. Diagnosis of COVID-19 at an early stage will prevent further infection and determine effective treatment to avoid illness and mortality. By identifying COVID-19 patients quickly we may be able to pre-emptively treat or step-up care, which could impact their disease trajectory.
Fortress Combo Test
The new Fortress Influenza COVID-19 Combo Rapid Test provides critical information for clinicians by differentiating between the Flu A, Flu B and COVID-19 viruses.
As these viruses have overlapping symptoms it is going to be increasingly difficult, especially during winter season, to detect COVID-19 and instigate appropriate isolation and patient treatment. Utilising the COVID-19 antigen test officially validated by Porton Down, combined with proven Influenza A/B technology this test provides rapid results in just 15 minutes.
Optimise workflow and help reduce hospital admissions. Improving patient pathways, outcomes and experience.
An point-of-care test that can identify an acute respiratory infection and differentiate viral from bacterial causes.
An acute respiratory infection (ARI) is one of the most common single reason for outpatient office visits and antibiotic prescriptions. More than 90% of patients who present to their healthcare providers with the most common symptom of an ARI—an acute cough—have a syndrome caused by a virus. FebriDx can be used to help triage patients at the point of care to reduce diagnostic uncertainty and avoid unnecessary antibiotics. FebriDx has been shown to improve clinical management decisions in 48% of patients and reduce antibiotic prescriptions by 80%.